Mary Krause

Mary Krause is a seasoned professional with extensive experience in formulation development and scientific research, currently serving as the Director of Formulation Development in Sterile Product Development at Bristol Myers Squibb since July 2014. Prior roles within Bristol Myers Squibb include Associate Scientific Director, Principal Scientist, and Senior Research Investigator, after starting with the company in various research investigator positions. Prior to this, Mary Krause worked as a Scientist at Echogen Inc. and completed a postdoctoral fellowship at the University of Kansas in pharmaceutical chemistry, where research focused on the characterization of novel metal-binding peptides. Educational qualifications include a Ph.D. in Chemistry from the University of Kansas, an MS, and a BS in Chemistry from Missouri State University. Additional experience includes a co-op position at Genentech, contributing to the development of protein therapeutics through formulation interactions.